Three Seasons Wealth, LLC

Position in EXEL — Exelixis, Inc.

CIK 2044495 SALT LAKE CITY, UT

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,676,589

-$876,180 QoQ

Shares Held

30,814

-48.2% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#281

of 751 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Three Seasons Wealth, LLC holds $2,869,679 across 5 Biotechnology names. EXEL ranks #1 (58.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	30,814	$1,676,589
2	SRRK	Scholar Rock Holding Corp	11,068	$608,740
3	RVMD	Revolution Medicines, Inc.	1,765	$330,549
4	SMMT	Summit Therapeutics Inc.	12,869	$187,501
5	SPRO	Spero Therapeutics, Inc.	30,000	$66,300

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,676,589	30,814	-48.2%	Shares	Sole	2026-08-13
2026-03-31	$2,552,769	59,519	+345.6%	Shares	Sole	2026-05-05
2025-12-31	$585,437	13,357	-52.8%	Shares	Sole	2026-01-15
2025-09-30	$1,167,798	28,276	—	Shares	Sole	2025-10-17
No filing history on record for this holder in this stock.